Eli Lilly and Company Return on Assets:
14.01% for March 31, 2013Eli Lilly and Company Historical Return on Assets Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 14.01% |
| Dec. 31, 2012 | 12.28% |
| Sept. 30, 2012 | 12.48% |
| June 30, 2012 | 12.32% |
| March 31, 2012 | 13.17% |
| Dec. 31, 2011 | 13.40% |
| Sept. 30, 2011 | 14.70% |
| June 30, 2011 | 15.43% |
| March 31, 2011 | 16.53% |
| Dec. 31, 2010 | 17.69% |
| Sept. 30, 2010 | 17.27% |
| June 30, 2010 | 16.32% |
| March 31, 2010 | 15.76% |
| Dec. 31, 2009 | 15.76% |
| Sept. 30, 2009 | -0.78% |
| June 30, 2009 | -5.87% |
| March 31, 2009 | -6.58% |
| Dec. 31, 2008 | -7.47% |
| Sept. 30, 2008 | 8.96% |
| June 30, 2008 | 14.53% |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Return on Assets
Return on Assets (ROA) shows the rate of return (after tax) being earned on all of the firm's assets regardless of financing structure (debt vs. equity). It is a measure of how efficiently the company is using all stakeholders' assets to earn returns.
Because ROA can differ significantly across firms, ROA is often used to compare a company over time or against companies that have similar financing structures.
Learn More
LLY Return on Assets Benchmarks
| Companies | |
|---|---|
| Pfizer | 7.88% |
| Merck | 5.83% |
| Bristol-Myers Squibb | 4.27% |
LLY Return on Assets Rankings
| Overall |
95th percentile 368 of 7593 |
| Sector |
92nd percentile 46 of 650 in Healthcare |
| Industry |
92nd percentile 4 of 52 in Drug Manufacturers - Major |
LLY Return on Assets Range, Past 5 Years
| Minimum | -7.47% | Dec 2008 |
| Maximum | 17.69% | Dec 2010 |
| Average | 10.50% |